nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C9—Capecitabine—colon cancer	0.0981	0.321	CbGbCtD
Eszopiclone—CYP2C8—Fluorouracil—colon cancer	0.0834	0.273	CbGbCtD
Eszopiclone—CYP2C9—Fluorouracil—colon cancer	0.0581	0.19	CbGbCtD
Eszopiclone—CYP3A4—Irinotecan—colon cancer	0.0352	0.115	CbGbCtD
Eszopiclone—CYP3A4—Vincristine—colon cancer	0.0308	0.101	CbGbCtD
Eszopiclone—Irritability—Capecitabine—colon cancer	0.00163	0.00234	CcSEcCtD
Eszopiclone—Mood swings—Capecitabine—colon cancer	0.00161	0.00233	CcSEcCtD
Eszopiclone—Ataxia—Capecitabine—colon cancer	0.0016	0.00231	CcSEcCtD
Eszopiclone—Alopecia—Vincristine—colon cancer	0.0016	0.0023	CcSEcCtD
Eszopiclone—Dehydration—Capecitabine—colon cancer	0.00158	0.00228	CcSEcCtD
Eszopiclone—Chills—Irinotecan—colon cancer	0.00158	0.00228	CcSEcCtD
Eszopiclone—Mouth ulceration—Methotrexate—colon cancer	0.00158	0.00228	CcSEcCtD
Eszopiclone—Bladder pain—Methotrexate—colon cancer	0.00158	0.00228	CcSEcCtD
Eszopiclone—Gynaecomastia—Methotrexate—colon cancer	0.00156	0.00225	CcSEcCtD
Eszopiclone—Dry skin—Capecitabine—colon cancer	0.00156	0.00225	CcSEcCtD
Eszopiclone—Alopecia—Irinotecan—colon cancer	0.00156	0.00224	CcSEcCtD
Eszopiclone—Hypokalaemia—Capecitabine—colon cancer	0.00155	0.00223	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00153	0.00221	CcSEcCtD
Eszopiclone—Back pain—Vincristine—colon cancer	0.00152	0.00219	CcSEcCtD
Eszopiclone—Gastritis—Capecitabine—colon cancer	0.00151	0.00217	CcSEcCtD
Eszopiclone—Muscular weakness—Capecitabine—colon cancer	0.0015	0.00217	CcSEcCtD
Eszopiclone—Alopecia—Fluorouracil—colon cancer	0.00149	0.00215	CcSEcCtD
Eszopiclone—Lymphadenopathy—Methotrexate—colon cancer	0.00149	0.00214	CcSEcCtD
Eszopiclone—Back pain—Irinotecan—colon cancer	0.00148	0.00214	CcSEcCtD
Eszopiclone—Muscle spasms—Irinotecan—colon cancer	0.00147	0.00212	CcSEcCtD
Eszopiclone—Influenza—Capecitabine—colon cancer	0.00147	0.00212	CcSEcCtD
Eszopiclone—Dysphagia—Capecitabine—colon cancer	0.00147	0.00212	CcSEcCtD
Eszopiclone—Asthma—Capecitabine—colon cancer	0.00147	0.00212	CcSEcCtD
Eszopiclone—Thrombophlebitis—Methotrexate—colon cancer	0.00146	0.00211	CcSEcCtD
Eszopiclone—Anaemia—Vincristine—colon cancer	0.00145	0.0021	CcSEcCtD
Eszopiclone—Agitation—Vincristine—colon cancer	0.00145	0.00209	CcSEcCtD
Eszopiclone—Photosensitivity—Methotrexate—colon cancer	0.00144	0.00208	CcSEcCtD
Eszopiclone—Ill-defined disorder—Irinotecan—colon cancer	0.00142	0.00205	CcSEcCtD
Eszopiclone—Anaemia—Irinotecan—colon cancer	0.00142	0.00204	CcSEcCtD
Eszopiclone—Bronchitis—Capecitabine—colon cancer	0.00142	0.00204	CcSEcCtD
Eszopiclone—Vertigo—Vincristine—colon cancer	0.00141	0.00204	CcSEcCtD
Eszopiclone—Vision blurred—Fluorouracil—colon cancer	0.00138	0.00199	CcSEcCtD
Eszopiclone—Malaise—Irinotecan—colon cancer	0.00138	0.00199	CcSEcCtD
Eszopiclone—Vertigo—Irinotecan—colon cancer	0.00138	0.00199	CcSEcCtD
Eszopiclone—Dysuria—Capecitabine—colon cancer	0.00138	0.00198	CcSEcCtD
Eszopiclone—Convulsion—Vincristine—colon cancer	0.00136	0.00197	CcSEcCtD
Eszopiclone—Hypertension—Vincristine—colon cancer	0.00136	0.00196	CcSEcCtD
Eszopiclone—Anaemia—Fluorouracil—colon cancer	0.00136	0.00196	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Capecitabine—colon cancer	0.00134	0.00194	CcSEcCtD
Eszopiclone—Myalgia—Vincristine—colon cancer	0.00134	0.00193	CcSEcCtD
Eszopiclone—Weight increased—Capecitabine—colon cancer	0.00134	0.00193	CcSEcCtD
Eszopiclone—Weight decreased—Capecitabine—colon cancer	0.00133	0.00192	CcSEcCtD
Eszopiclone—Hypertension—Irinotecan—colon cancer	0.00132	0.00191	CcSEcCtD
Eszopiclone—Depression—Capecitabine—colon cancer	0.00131	0.00189	CcSEcCtD
Eszopiclone—Discomfort—Irinotecan—colon cancer	0.00129	0.00186	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Capecitabine—colon cancer	0.00129	0.00186	CcSEcCtD
Eszopiclone—Anaphylactic shock—Vincristine—colon cancer	0.00128	0.00185	CcSEcCtD
Eszopiclone—Stomatitis—Capecitabine—colon cancer	0.00128	0.00184	CcSEcCtD
Eszopiclone—Infection—Vincristine—colon cancer	0.00128	0.00184	CcSEcCtD
Eszopiclone—Conjunctivitis—Capecitabine—colon cancer	0.00128	0.00184	CcSEcCtD
Eszopiclone—Urinary tract infection—Capecitabine—colon cancer	0.00128	0.00184	CcSEcCtD
Eszopiclone—Convulsion—Fluorouracil—colon cancer	0.00127	0.00183	CcSEcCtD
Eszopiclone—Osteoarthritis—Methotrexate—colon cancer	0.00127	0.00183	CcSEcCtD
Eszopiclone—Confusional state—Irinotecan—colon cancer	0.00126	0.00182	CcSEcCtD
Eszopiclone—Haematuria—Capecitabine—colon cancer	0.00125	0.0018	CcSEcCtD
Eszopiclone—Anaphylactic shock—Irinotecan—colon cancer	0.00125	0.0018	CcSEcCtD
Eszopiclone—Chest pain—Fluorouracil—colon cancer	0.00125	0.0018	CcSEcCtD
Eszopiclone—Myalgia—Fluorouracil—colon cancer	0.00125	0.0018	CcSEcCtD
Eszopiclone—Infection—Irinotecan—colon cancer	0.00124	0.00179	CcSEcCtD
Eszopiclone—Hyperhidrosis—Vincristine—colon cancer	0.00124	0.00179	CcSEcCtD
Eszopiclone—Epistaxis—Capecitabine—colon cancer	0.00124	0.00178	CcSEcCtD
Eszopiclone—Discomfort—Fluorouracil—colon cancer	0.00123	0.00178	CcSEcCtD
Eszopiclone—Anorexia—Vincristine—colon cancer	0.00122	0.00177	CcSEcCtD
Eszopiclone—Irritability—Methotrexate—colon cancer	0.00121	0.00174	CcSEcCtD
Eszopiclone—Hyperhidrosis—Irinotecan—colon cancer	0.00121	0.00174	CcSEcCtD
Eszopiclone—Confusional state—Fluorouracil—colon cancer	0.00121	0.00174	CcSEcCtD
Eszopiclone—Mood swings—Methotrexate—colon cancer	0.0012	0.00173	CcSEcCtD
Eszopiclone—Anaphylactic shock—Fluorouracil—colon cancer	0.0012	0.00173	CcSEcCtD
Eszopiclone—Anorexia—Irinotecan—colon cancer	0.00119	0.00172	CcSEcCtD
Eszopiclone—Ataxia—Methotrexate—colon cancer	0.00119	0.00172	CcSEcCtD
Eszopiclone—Infection—Fluorouracil—colon cancer	0.00119	0.00172	CcSEcCtD
Eszopiclone—Rhinitis—Capecitabine—colon cancer	0.00118	0.0017	CcSEcCtD
Eszopiclone—Hepatitis—Capecitabine—colon cancer	0.00118	0.0017	CcSEcCtD
Eszopiclone—Hypoaesthesia—Capecitabine—colon cancer	0.00117	0.00169	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00117	0.00169	CcSEcCtD
Eszopiclone—Pharyngitis—Capecitabine—colon cancer	0.00117	0.00169	CcSEcCtD
Eszopiclone—Tachycardia—Fluorouracil—colon cancer	0.00117	0.00169	CcSEcCtD
Eszopiclone—Insomnia—Vincristine—colon cancer	0.00116	0.00167	CcSEcCtD
Eszopiclone—Oedema peripheral—Capecitabine—colon cancer	0.00116	0.00167	CcSEcCtD
Eszopiclone—Paraesthesia—Vincristine—colon cancer	0.00115	0.00166	CcSEcCtD
Eszopiclone—Anorexia—Fluorouracil—colon cancer	0.00114	0.00165	CcSEcCtD
Eszopiclone—Insomnia—Irinotecan—colon cancer	0.00113	0.00163	CcSEcCtD
Eszopiclone—Paraesthesia—Irinotecan—colon cancer	0.00112	0.00162	CcSEcCtD
Eszopiclone—Decreased appetite—Vincristine—colon cancer	0.00112	0.00161	CcSEcCtD
Eszopiclone—Dyspnoea—Irinotecan—colon cancer	0.00111	0.00161	CcSEcCtD
Eszopiclone—Erythema multiforme—Capecitabine—colon cancer	0.00111	0.00161	CcSEcCtD
Eszopiclone—Somnolence—Irinotecan—colon cancer	0.00111	0.0016	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Vincristine—colon cancer	0.00111	0.0016	CcSEcCtD
Eszopiclone—Fatigue—Vincristine—colon cancer	0.00111	0.0016	CcSEcCtD
Eszopiclone—Dyspepsia—Irinotecan—colon cancer	0.0011	0.00159	CcSEcCtD
Eszopiclone—Tinnitus—Capecitabine—colon cancer	0.0011	0.00158	CcSEcCtD
Eszopiclone—Pain—Vincristine—colon cancer	0.0011	0.00158	CcSEcCtD
Eszopiclone—Constipation—Vincristine—colon cancer	0.0011	0.00158	CcSEcCtD
Eszopiclone—Asthma—Methotrexate—colon cancer	0.0011	0.00158	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00109	0.00157	CcSEcCtD
Eszopiclone—Decreased appetite—Irinotecan—colon cancer	0.00109	0.00157	CcSEcCtD
Eszopiclone—Insomnia—Fluorouracil—colon cancer	0.00108	0.00156	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Irinotecan—colon cancer	0.00108	0.00156	CcSEcCtD
Eszopiclone—Fatigue—Irinotecan—colon cancer	0.00108	0.00155	CcSEcCtD
Eszopiclone—Paraesthesia—Fluorouracil—colon cancer	0.00108	0.00155	CcSEcCtD
Eszopiclone—Constipation—Irinotecan—colon cancer	0.00107	0.00154	CcSEcCtD
Eszopiclone—Pain—Irinotecan—colon cancer	0.00107	0.00154	CcSEcCtD
Eszopiclone—Dyspnoea—Fluorouracil—colon cancer	0.00107	0.00154	CcSEcCtD
Eszopiclone—Somnolence—Fluorouracil—colon cancer	0.00106	0.00154	CcSEcCtD
Eszopiclone—Chills—Capecitabine—colon cancer	0.00106	0.00152	CcSEcCtD
Eszopiclone—Dyspepsia—Fluorouracil—colon cancer	0.00105	0.00152	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Vincristine—colon cancer	0.00105	0.00151	CcSEcCtD
Eszopiclone—Decreased appetite—Fluorouracil—colon cancer	0.00104	0.0015	CcSEcCtD
Eszopiclone—Alopecia—Capecitabine—colon cancer	0.00104	0.0015	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00103	0.00149	CcSEcCtD
Eszopiclone—Feeling abnormal—Irinotecan—colon cancer	0.00103	0.00149	CcSEcCtD
Eszopiclone—Dysuria—Methotrexate—colon cancer	0.00102	0.00148	CcSEcCtD
Eszopiclone—Pain—Fluorouracil—colon cancer	0.00102	0.00148	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Irinotecan—colon cancer	0.00102	0.00147	CcSEcCtD
Eszopiclone—Body temperature increased—Vincristine—colon cancer	0.00101	0.00146	CcSEcCtD
Eszopiclone—Abdominal pain—Vincristine—colon cancer	0.00101	0.00146	CcSEcCtD
Eszopiclone—Erectile dysfunction—Methotrexate—colon cancer	0.00101	0.00146	CcSEcCtD
Eszopiclone—Dysgeusia—Capecitabine—colon cancer	0.001	0.00145	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Methotrexate—colon cancer	0.001	0.00144	CcSEcCtD
Eszopiclone—Back pain—Capecitabine—colon cancer	0.000992	0.00143	CcSEcCtD
Eszopiclone—Abdominal pain—Irinotecan—colon cancer	0.000988	0.00143	CcSEcCtD
Eszopiclone—Body temperature increased—Irinotecan—colon cancer	0.000988	0.00143	CcSEcCtD
Eszopiclone—Feeling abnormal—Fluorouracil—colon cancer	0.000987	0.00142	CcSEcCtD
Eszopiclone—Muscle spasms—Capecitabine—colon cancer	0.000986	0.00142	CcSEcCtD
Eszopiclone—Drowsiness—Methotrexate—colon cancer	0.000977	0.00141	CcSEcCtD
Eszopiclone—Depression—Methotrexate—colon cancer	0.000974	0.0014	CcSEcCtD
Eszopiclone—Vision blurred—Capecitabine—colon cancer	0.000966	0.00139	CcSEcCtD
Eszopiclone—Tremor—Capecitabine—colon cancer	0.000961	0.00139	CcSEcCtD
Eszopiclone—Stomatitis—Methotrexate—colon cancer	0.000952	0.00137	CcSEcCtD
Eszopiclone—Ill-defined disorder—Capecitabine—colon cancer	0.000951	0.00137	CcSEcCtD
Eszopiclone—Urticaria—Fluorouracil—colon cancer	0.000951	0.00137	CcSEcCtD
Eszopiclone—Conjunctivitis—Methotrexate—colon cancer	0.000949	0.00137	CcSEcCtD
Eszopiclone—Anaemia—Capecitabine—colon cancer	0.000948	0.00137	CcSEcCtD
Eszopiclone—Body temperature increased—Fluorouracil—colon cancer	0.000947	0.00137	CcSEcCtD
Eszopiclone—Hypersensitivity—Vincristine—colon cancer	0.000946	0.00136	CcSEcCtD
Eszopiclone—Sweating—Methotrexate—colon cancer	0.000936	0.00135	CcSEcCtD
Eszopiclone—Haematuria—Methotrexate—colon cancer	0.000931	0.00134	CcSEcCtD
Eszopiclone—Malaise—Capecitabine—colon cancer	0.000925	0.00133	CcSEcCtD
Eszopiclone—Epistaxis—Methotrexate—colon cancer	0.000921	0.00133	CcSEcCtD
Eszopiclone—Vertigo—Capecitabine—colon cancer	0.000921	0.00133	CcSEcCtD
Eszopiclone—Hypersensitivity—Irinotecan—colon cancer	0.000921	0.00133	CcSEcCtD
Eszopiclone—Asthenia—Vincristine—colon cancer	0.000921	0.00133	CcSEcCtD
Eszopiclone—Palpitations—Capecitabine—colon cancer	0.000906	0.00131	CcSEcCtD
Eszopiclone—Asthenia—Irinotecan—colon cancer	0.000897	0.00129	CcSEcCtD
Eszopiclone—Hypertension—Capecitabine—colon cancer	0.000885	0.00128	CcSEcCtD
Eszopiclone—Hypersensitivity—Fluorouracil—colon cancer	0.000882	0.00127	CcSEcCtD
Eszopiclone—Diarrhoea—Vincristine—colon cancer	0.000878	0.00127	CcSEcCtD
Eszopiclone—Hepatitis—Methotrexate—colon cancer	0.000877	0.00126	CcSEcCtD
Eszopiclone—Chest pain—Capecitabine—colon cancer	0.000873	0.00126	CcSEcCtD
Eszopiclone—Myalgia—Capecitabine—colon cancer	0.000873	0.00126	CcSEcCtD
Eszopiclone—Pharyngitis—Methotrexate—colon cancer	0.00087	0.00126	CcSEcCtD
Eszopiclone—Anxiety—Capecitabine—colon cancer	0.00087	0.00125	CcSEcCtD
Eszopiclone—Discomfort—Capecitabine—colon cancer	0.000863	0.00124	CcSEcCtD
Eszopiclone—Diarrhoea—Irinotecan—colon cancer	0.000856	0.00123	CcSEcCtD
Eszopiclone—Dry mouth—Capecitabine—colon cancer	0.000854	0.00123	CcSEcCtD
Eszopiclone—Dizziness—Vincristine—colon cancer	0.000849	0.00122	CcSEcCtD
Eszopiclone—Pruritus—Fluorouracil—colon cancer	0.000847	0.00122	CcSEcCtD
Eszopiclone—Confusional state—Capecitabine—colon cancer	0.000844	0.00122	CcSEcCtD
Eszopiclone—Infection—Capecitabine—colon cancer	0.000831	0.0012	CcSEcCtD
Eszopiclone—Erythema multiforme—Methotrexate—colon cancer	0.000829	0.0012	CcSEcCtD
Eszopiclone—Dizziness—Irinotecan—colon cancer	0.000827	0.00119	CcSEcCtD
Eszopiclone—Diarrhoea—Fluorouracil—colon cancer	0.000819	0.00118	CcSEcCtD
Eszopiclone—Tinnitus—Methotrexate—colon cancer	0.000818	0.00118	CcSEcCtD
Eszopiclone—Tachycardia—Capecitabine—colon cancer	0.000817	0.00118	CcSEcCtD
Eszopiclone—Vomiting—Vincristine—colon cancer	0.000816	0.00118	CcSEcCtD
Eszopiclone—Rash—Vincristine—colon cancer	0.00081	0.00117	CcSEcCtD
Eszopiclone—Hyperhidrosis—Capecitabine—colon cancer	0.000809	0.00117	CcSEcCtD
Eszopiclone—Dermatitis—Vincristine—colon cancer	0.000809	0.00117	CcSEcCtD
Eszopiclone—Headache—Vincristine—colon cancer	0.000804	0.00116	CcSEcCtD
Eszopiclone—Anorexia—Capecitabine—colon cancer	0.000798	0.00115	CcSEcCtD
Eszopiclone—Vomiting—Irinotecan—colon cancer	0.000795	0.00115	CcSEcCtD
Eszopiclone—Dizziness—Fluorouracil—colon cancer	0.000792	0.00114	CcSEcCtD
Eszopiclone—Rash—Irinotecan—colon cancer	0.000788	0.00114	CcSEcCtD
Eszopiclone—Dermatitis—Irinotecan—colon cancer	0.000788	0.00114	CcSEcCtD
Eszopiclone—Chills—Methotrexate—colon cancer	0.000787	0.00113	CcSEcCtD
Eszopiclone—Headache—Irinotecan—colon cancer	0.000783	0.00113	CcSEcCtD
Eszopiclone—Alopecia—Methotrexate—colon cancer	0.000775	0.00112	CcSEcCtD
Eszopiclone—Nausea—Vincristine—colon cancer	0.000763	0.0011	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000762	0.0011	CcSEcCtD
Eszopiclone—Vomiting—Fluorouracil—colon cancer	0.000761	0.0011	CcSEcCtD
Eszopiclone—Insomnia—Capecitabine—colon cancer	0.000757	0.00109	CcSEcCtD
Eszopiclone—Rash—Fluorouracil—colon cancer	0.000755	0.00109	CcSEcCtD
Eszopiclone—Dermatitis—Fluorouracil—colon cancer	0.000754	0.00109	CcSEcCtD
Eszopiclone—Paraesthesia—Capecitabine—colon cancer	0.000751	0.00108	CcSEcCtD
Eszopiclone—Headache—Fluorouracil—colon cancer	0.00075	0.00108	CcSEcCtD
Eszopiclone—Dysgeusia—Methotrexate—colon cancer	0.000747	0.00108	CcSEcCtD
Eszopiclone—Dyspnoea—Capecitabine—colon cancer	0.000746	0.00108	CcSEcCtD
Eszopiclone—Nausea—Irinotecan—colon cancer	0.000743	0.00107	CcSEcCtD
Eszopiclone—Back pain—Methotrexate—colon cancer	0.000738	0.00106	CcSEcCtD
Eszopiclone—Dyspepsia—Capecitabine—colon cancer	0.000737	0.00106	CcSEcCtD
Eszopiclone—Decreased appetite—Capecitabine—colon cancer	0.000727	0.00105	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000722	0.00104	CcSEcCtD
Eszopiclone—Fatigue—Capecitabine—colon cancer	0.000721	0.00104	CcSEcCtD
Eszopiclone—Vision blurred—Methotrexate—colon cancer	0.000719	0.00104	CcSEcCtD
Eszopiclone—Pain—Capecitabine—colon cancer	0.000716	0.00103	CcSEcCtD
Eszopiclone—Constipation—Capecitabine—colon cancer	0.000716	0.00103	CcSEcCtD
Eszopiclone—Nausea—Fluorouracil—colon cancer	0.000711	0.00103	CcSEcCtD
Eszopiclone—Ill-defined disorder—Methotrexate—colon cancer	0.000708	0.00102	CcSEcCtD
Eszopiclone—Anaemia—Methotrexate—colon cancer	0.000706	0.00102	CcSEcCtD
Eszopiclone—Feeling abnormal—Capecitabine—colon cancer	0.00069	0.000995	CcSEcCtD
Eszopiclone—Malaise—Methotrexate—colon cancer	0.000688	0.000993	CcSEcCtD
Eszopiclone—Vertigo—Methotrexate—colon cancer	0.000686	0.000989	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Capecitabine—colon cancer	0.000684	0.000987	CcSEcCtD
Eszopiclone—Urticaria—Capecitabine—colon cancer	0.000665	0.000959	CcSEcCtD
Eszopiclone—Body temperature increased—Capecitabine—colon cancer	0.000662	0.000954	CcSEcCtD
Eszopiclone—Abdominal pain—Capecitabine—colon cancer	0.000662	0.000954	CcSEcCtD
Eszopiclone—Convulsion—Methotrexate—colon cancer	0.000661	0.000954	CcSEcCtD
Eszopiclone—Myalgia—Methotrexate—colon cancer	0.00065	0.000937	CcSEcCtD
Eszopiclone—Chest pain—Methotrexate—colon cancer	0.00065	0.000937	CcSEcCtD
Eszopiclone—Discomfort—Methotrexate—colon cancer	0.000642	0.000926	CcSEcCtD
Eszopiclone—Confusional state—Methotrexate—colon cancer	0.000628	0.000906	CcSEcCtD
Eszopiclone—Anaphylactic shock—Methotrexate—colon cancer	0.000623	0.000898	CcSEcCtD
Eszopiclone—Infection—Methotrexate—colon cancer	0.000619	0.000893	CcSEcCtD
Eszopiclone—Hypersensitivity—Capecitabine—colon cancer	0.000617	0.000889	CcSEcCtD
Eszopiclone—Hyperhidrosis—Methotrexate—colon cancer	0.000602	0.000869	CcSEcCtD
Eszopiclone—Asthenia—Capecitabine—colon cancer	0.0006	0.000866	CcSEcCtD
Eszopiclone—Anorexia—Methotrexate—colon cancer	0.000594	0.000856	CcSEcCtD
Eszopiclone—Pruritus—Capecitabine—colon cancer	0.000592	0.000854	CcSEcCtD
Eszopiclone—Diarrhoea—Capecitabine—colon cancer	0.000573	0.000826	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000568	0.000819	CcSEcCtD
Eszopiclone—Insomnia—Methotrexate—colon cancer	0.000563	0.000813	CcSEcCtD
Eszopiclone—Paraesthesia—Methotrexate—colon cancer	0.000559	0.000807	CcSEcCtD
Eszopiclone—Dyspnoea—Methotrexate—colon cancer	0.000555	0.000801	CcSEcCtD
Eszopiclone—Somnolence—Methotrexate—colon cancer	0.000554	0.000799	CcSEcCtD
Eszopiclone—Dizziness—Capecitabine—colon cancer	0.000553	0.000798	CcSEcCtD
Eszopiclone—Dyspepsia—Methotrexate—colon cancer	0.000548	0.000791	CcSEcCtD
Eszopiclone—Decreased appetite—Methotrexate—colon cancer	0.000542	0.000781	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000538	0.000776	CcSEcCtD
Eszopiclone—Fatigue—Methotrexate—colon cancer	0.000537	0.000775	CcSEcCtD
Eszopiclone—Pain—Methotrexate—colon cancer	0.000533	0.000768	CcSEcCtD
Eszopiclone—Vomiting—Capecitabine—colon cancer	0.000532	0.000767	CcSEcCtD
Eszopiclone—Rash—Capecitabine—colon cancer	0.000528	0.000761	CcSEcCtD
Eszopiclone—Dermatitis—Capecitabine—colon cancer	0.000527	0.00076	CcSEcCtD
Eszopiclone—Headache—Capecitabine—colon cancer	0.000524	0.000756	CcSEcCtD
Eszopiclone—Feeling abnormal—Methotrexate—colon cancer	0.000513	0.00074	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Methotrexate—colon cancer	0.000509	0.000735	CcSEcCtD
Eszopiclone—Nausea—Capecitabine—colon cancer	0.000497	0.000717	CcSEcCtD
Eszopiclone—Urticaria—Methotrexate—colon cancer	0.000495	0.000714	CcSEcCtD
Eszopiclone—Abdominal pain—Methotrexate—colon cancer	0.000492	0.00071	CcSEcCtD
Eszopiclone—Body temperature increased—Methotrexate—colon cancer	0.000492	0.00071	CcSEcCtD
Eszopiclone—Hypersensitivity—Methotrexate—colon cancer	0.000459	0.000662	CcSEcCtD
Eszopiclone—Asthenia—Methotrexate—colon cancer	0.000447	0.000645	CcSEcCtD
Eszopiclone—Pruritus—Methotrexate—colon cancer	0.000441	0.000636	CcSEcCtD
Eszopiclone—Diarrhoea—Methotrexate—colon cancer	0.000426	0.000615	CcSEcCtD
Eszopiclone—Dizziness—Methotrexate—colon cancer	0.000412	0.000594	CcSEcCtD
Eszopiclone—Vomiting—Methotrexate—colon cancer	0.000396	0.000571	CcSEcCtD
Eszopiclone—Rash—Methotrexate—colon cancer	0.000393	0.000567	CcSEcCtD
Eszopiclone—Dermatitis—Methotrexate—colon cancer	0.000392	0.000566	CcSEcCtD
Eszopiclone—Headache—Methotrexate—colon cancer	0.00039	0.000563	CcSEcCtD
Eszopiclone—Nausea—Methotrexate—colon cancer	0.00037	0.000534	CcSEcCtD
Eszopiclone—TSPO—blood vessel—colon cancer	0.000106	0.105	CbGeAlD
Eszopiclone—PTGS1—endothelium—colon cancer	6.42e-05	0.0631	CbGeAlD
Eszopiclone—TSPO—embryo—colon cancer	6.35e-05	0.0624	CbGeAlD
Eszopiclone—PTGS1—blood vessel—colon cancer	5.92e-05	0.0582	CbGeAlD
Eszopiclone—TSPO—epithelium—colon cancer	5.18e-05	0.0509	CbGeAlD
Eszopiclone—TSPO—smooth muscle tissue—colon cancer	4.99e-05	0.0491	CbGeAlD
Eszopiclone—TSPO—renal system—colon cancer	4.81e-05	0.0472	CbGeAlD
Eszopiclone—TSPO—lymphoid tissue—colon cancer	3.99e-05	0.0392	CbGeAlD
Eszopiclone—TSPO—digestive system—colon cancer	3.94e-05	0.0387	CbGeAlD
Eszopiclone—GABRA2—vagina—colon cancer	3.76e-05	0.0369	CbGeAlD
Eszopiclone—TSPO—bone marrow—colon cancer	3.63e-05	0.0357	CbGeAlD
Eszopiclone—TSPO—vagina—colon cancer	3.48e-05	0.0342	CbGeAlD
Eszopiclone—CYP2C8—renal system—colon cancer	3.3e-05	0.0324	CbGeAlD
Eszopiclone—TSPO—liver—colon cancer	2.94e-05	0.0289	CbGeAlD
Eszopiclone—PTGS1—epithelium—colon cancer	2.88e-05	0.0283	CbGeAlD
Eszopiclone—PTGS1—smooth muscle tissue—colon cancer	2.78e-05	0.0273	CbGeAlD
Eszopiclone—PTGS1—renal system—colon cancer	2.67e-05	0.0263	CbGeAlD
Eszopiclone—GABRA2—lymph node—colon cancer	2.43e-05	0.0239	CbGeAlD
Eszopiclone—CYP2C9—digestive system—colon cancer	2.4e-05	0.0236	CbGeAlD
Eszopiclone—CYP2C8—vagina—colon cancer	2.39e-05	0.0235	CbGeAlD
Eszopiclone—TSPO—lymph node—colon cancer	2.25e-05	0.0221	CbGeAlD
Eszopiclone—CYP3A4—renal system—colon cancer	2.23e-05	0.022	CbGeAlD
Eszopiclone—PTGS1—digestive system—colon cancer	2.19e-05	0.0216	CbGeAlD
Eszopiclone—CYP2C8—liver—colon cancer	2.02e-05	0.0198	CbGeAlD
Eszopiclone—PTGS1—vagina—colon cancer	1.94e-05	0.019	CbGeAlD
Eszopiclone—CYP3A4—digestive system—colon cancer	1.83e-05	0.018	CbGeAlD
Eszopiclone—CYP2C9—liver—colon cancer	1.79e-05	0.0176	CbGeAlD
Eszopiclone—CYP3A4—liver—colon cancer	1.37e-05	0.0134	CbGeAlD
Eszopiclone—PTGS1—lymph node—colon cancer	1.25e-05	0.0123	CbGeAlD
